Joanne Guerrero
Family · Montebello, CANPI 1023654779
Payments from drug & device makers
Across 40 payments — averaging $109.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$692
- Teva Pharmaceuticals USA, Inc.$484
- AbbVie$371
- Abbott$291
- Boston Scientific$250
- Sanofi$226
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,380100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 6 | $692 |
| Teva Pharmaceuticals USA, Inc. | 4 | $484 |
| AbbVie | 3 | $371 |
| Abbott | 4 | $291 |
| Boston Scientific | 2 | $250 |
| Sanofi | 2 | $226 |
| Regeneron Healthcare Solutions, Inc. | 2 | $222 |
| Neurocrine Biosciences, Inc. | 1 | $174 |
| Alnylam Pharmaceuticals Inc. | 1 | $144 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $142 |
| Silk Road Medical, Inc. | 1 | $133 |
| Novo Nordisk | 1 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Shield Therapeutics Inc | 1 | $124 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $122 |
| Myovant Sciences Inc. | 1 | $121 |
| Bayer | 1 | $111 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
| Medtronic | 1 | $97 |
| Biogen | 1 | $95 |
| AstraZeneca | 1 | $50 |
| Johnson & Johnson | 1 | $27 |
| Merck | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$392
- UBRELVY$371
- Austedo XR$248
- QULIPTA$246
- DUPIXENT$240
- INGREZZA$174
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$156
- ONPATTRO$144
- CAPLYTA$142
- Edwards SAPIEN 3 Transcatheter Heart Valve$142
- ENROUTE Transcarotid Stent$133
- ENROUTE Transcarotid Neuroprotection System$133
- GENERAL PAIN MANAGEMENT$125
- UZEDY$125
- ZENPEP$125
- ACCRUFER$124
- Alinity$122
- XIFAXAN$122
- MYFEMBREE$121
- AJOVY$111
How this compares
$4,382 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 20 | $231 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $212 |
| Cephalexin | 14 | $118 |
Paid to pharmacies, not to this prescriber.
Other family in Montebello
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.